Patent · US Active

Allergen

US9164101B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignee

PHADIA AB · SE

Inventors

Lars Mattsson · Uppsala, SE
Jonas Lidholm · Knivsta, SE
Thomas Lundgren · Uppsala, SE

Key dates

Filing date	Apr 26, 2011
Grant date	Oct 20, 2015
Priority date	—
Expiry date	Apr 26, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/24
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An isolated horse allergen is disclosed which is a secretoglobin having a molecular weight of 15 kDa under non-reducing conditions and comprising a first peptide chain having a molecular weight of about 5 kDa and a second peptide chain having a molecular weight of about 10 kDa linked together, and variants and fragments thereof sharing epitopes for antibodies therewith. The use of the allergen in diagnosis and therapy is also disclosed as well as a diagnostic kit and a pharmaceutical composition containing the allergen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.